Table of Contents 1 Study Coverage 1.1 Nuclear Medicine Product 1.2 Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global Nuclear Medicine Market Size Growth Rate by Product 1.4.2 Tc-99 1.4.3 I-123/131 1.4.4 In-111 1.4.5 Xe-133 1.4.6 Th-201 1.4.7 Ga-67 1.4.8 Other 1.5 Market by End User 1.5.1 Global Nuclear Medicine Market Size Growth Rate by End User 1.5.2 Diagnostic 1.5.3 Therapeutic 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Nuclear Medicine Market Size 2.1.1 Global Nuclear Medicine Revenue 2014-2025 2.1.2 Global Nuclear Medicine Sales 2014-2025 2.2 Nuclear Medicine Growth Rate by Regions 2.2.1 Global Nuclear Medicine Sales by Regions 2.2.2 Global Nuclear Medicine Revenue by Regions 3 Breakdown Data by Manufacturers 3.1 Nuclear Medicine Sales by Manufacturers 3.1.1 Nuclear Medicine Sales by Manufacturers 3.1.2 Nuclear Medicine Sales Market Share by Manufacturers 3.1.3 Global Nuclear Medicine Market Concentration Ratio (CR5 and HHI) 3.2 Nuclear Medicine Revenue by Manufacturers 3.2.1 Nuclear Medicine Revenue by Manufacturers (2014-2019) 3.2.2 Nuclear Medicine Revenue Share by Manufacturers (2014-2019) 3.3 Nuclear Medicine Price by Manufacturers 3.4 Nuclear Medicine Manufacturing Base Distribution, Product Types 3.4.1 Nuclear Medicine Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Nuclear Medicine Product Type 3.4.3 Date of International Manufacturers Enter into Nuclear Medicine Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Product 4.1 Global Nuclear Medicine Sales by Product 4.2 Global Nuclear Medicine Revenue by Product 4.3 Nuclear Medicine Price by Product 5 Breakdown Data by End User 5.1 Overview 5.2 Global Nuclear Medicine Breakdown Data by End User 6 North America 6.1 North America Nuclear Medicine by Countries 6.1.1 North America Nuclear Medicine Sales by Countries 6.1.2 North America Nuclear Medicine Revenue by Countries 6.1.3 United States 6.1.4 Canada 6.1.5 Mexico 6.2 North America Nuclear Medicine by Product 6.3 North America Nuclear Medicine by End User 7 Europe 7.1 Europe Nuclear Medicine by Countries 7.1.1 Europe Nuclear Medicine Sales by Countries 7.1.2 Europe Nuclear Medicine Revenue by Countries 7.1.3 Germany 7.1.4 France 7.1.5 UK 7.1.6 Italy 7.1.7 Russia 7.2 Europe Nuclear Medicine by Product 7.3 Europe Nuclear Medicine by End User 8 Asia Pacific 8.1 Asia Pacific Nuclear Medicine by Countries 8.1.1 Asia Pacific Nuclear Medicine Sales by Countries 8.1.2 Asia Pacific Nuclear Medicine Revenue by Countries 8.1.3 China 8.1.4 Japan 8.1.5 Korea 8.1.6 India 8.1.7 Australia 8.1.8 Indonesia 8.1.9 Malaysia 8.1.10 Philippines 8.1.11 Thailand 8.1.12 Vietnam 8.1.13 Singapore 8.2 Asia Pacific Nuclear Medicine by Product 8.3 Asia Pacific Nuclear Medicine by End User 9 Central & South America 9.1 Central & South America Nuclear Medicine by Countries 9.1.1 Central & South America Nuclear Medicine Sales by Countries 9.1.2 Central & South America Nuclear Medicine Revenue by Countries 9.1.3 Brazil 9.2 Central & South America Nuclear Medicine by Product 9.3 Central & South America Nuclear Medicine by End User 10 Middle East and Africa 10.1 Middle East and Africa Nuclear Medicine by Countries 10.1.1 Middle East and Africa Nuclear Medicine Sales by Countries 10.1.2 Middle East and Africa Nuclear Medicine Revenue by Countries 10.1.3 GCC Countries 10.1.4 Turkey 10.1.5 Egypt 10.1.6 South Africa 10.2 Middle East and Africa Nuclear Medicine by Product 10.3 Middle East and Africa Nuclear Medicine by End User 11 Company Profiles 11.1 GE Healthcare 11.1.1 GE Healthcare Company Details 11.1.2 Company Business Overview 11.1.3 GE Healthcare Nuclear Medicine Sales, Revenue and Gross Margin (2014-2019) 11.1.4 GE Healthcare Nuclear Medicine Products Offered 11.1.5 GE Healthcare Recent Development 11.2 Bracco Imaging 11.2.1 Bracco Imaging Company Details 11.2.2 Company Business Overview 11.2.3 Bracco Imaging Nuclear Medicine Sales, Revenue and Gross Margin (2014-2019) 11.2.4 Bracco Imaging Nuclear Medicine Products Offered 11.2.5 Bracco Imaging Recent Development 11.3 Mallinckrodt 11.3.1 Mallinckrodt Company Details 11.3.2 Company Business Overview 11.3.3 Mallinckrodt Nuclear Medicine Sales, Revenue and Gross Margin (2014-2019) 11.3.4 Mallinckrodt Nuclear Medicine Products Offered 11.3.5 Mallinckrodt Recent Development 11.4 Lantheus Medical Imaging 11.4.1 Lantheus Medical Imaging Company Details 11.4.2 Company Business Overview 11.4.3 Lantheus Medical Imaging Nuclear Medicine Sales, Revenue and Gross Margin (2014-2019) 11.4.4 Lantheus Medical Imaging Nuclear Medicine Products Offered 11.4.5 Lantheus Medical Imaging Recent Development 11.5 Bayer 11.5.1 Bayer Company Details 11.5.2 Company Business Overview 11.5.3 Bayer Nuclear Medicine Sales, Revenue and Gross Margin (2014-2019) 11.5.4 Bayer Nuclear Medicine Products Offered 11.5.5 Bayer Recent Development 11.6 Triad Isotopes 11.6.1 Triad Isotopes Company Details 11.6.2 Company Business Overview 11.6.3 Triad Isotopes Nuclear Medicine Sales, Revenue and Gross Margin (2014-2019) 11.6.4 Triad Isotopes Nuclear Medicine Products Offered 11.6.5 Triad Isotopes Recent Development 11.7 Nordion 11.7.1 Nordion Company Details 11.7.2 Company Business Overview 11.7.3 Nordion Nuclear Medicine Sales, Revenue and Gross Margin (2014-2019) 11.7.4 Nordion Nuclear Medicine Products Offered 11.7.5 Nordion Recent Development 11.8 Jubilant Pharma 11.8.1 Jubilant Pharma Company Details 11.8.2 Company Business Overview 11.8.3 Jubilant Pharma Nuclear Medicine Sales, Revenue and Gross Margin (2014-2019) 11.8.4 Jubilant Pharma Nuclear Medicine Products Offered 11.8.5 Jubilant Pharma Recent Development 11.9 Eli Lilly 11.9.1 Eli Lilly Company Details 11.9.2 Company Business Overview 11.9.3 Eli Lilly Nuclear Medicine Sales, Revenue and Gross Margin (2014-2019) 11.9.4 Eli Lilly Nuclear Medicine Products Offered 11.9.5 Eli Lilly Recent Development 11.10 SIEMENS 11.10.1 SIEMENS Company Details 11.10.2 Company Business Overview 11.10.3 SIEMENS Nuclear Medicine Sales, Revenue and Gross Margin (2014-2019) 11.10.4 SIEMENS Nuclear Medicine Products Offered 11.10.5 SIEMENS Recent Development 11.11 China Isotope & Radiation 11.12 Dongcheng 12 Future Forecast 12.1 Nuclear Medicine Market Forecast by Regions 12.1.1 Global Nuclear Medicine Sales Forecast by Regions 2019-2025 12.1.2 Global Nuclear Medicine Revenue Forecast by Regions 2019-2025 12.2 Nuclear Medicine Market Forecast by Product 12.2.1 Global Nuclear Medicine Sales Forecast by Product 2019-2025 12.2.2 Global Nuclear Medicine Revenue Forecast by Product 2019-2025 12.3 Nuclear Medicine Market Forecast by End User 12.4 North America Nuclear Medicine Forecast 12.5 Europe Nuclear Medicine Forecast 12.6 Asia Pacific Nuclear Medicine Forecast 12.7 Central & South America Nuclear Medicine Forecast 12.8 Middle East and Africa Nuclear Medicine Forecast 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Macroscopic Indicators 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Nuclear Medicine Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables and Figures Figure Nuclear Medicine Product Picture Table Nuclear Medicine Market Segments Table Key Manufacturers Nuclear Medicine Covered Table Global Nuclear Medicine Market Size Growth Rate by Product 2019-2025 (M Dose) & (Million US$) Figure Global Nuclear Medicine Sales Market Share by Product 2014-2025 Figure Tc-99 Product Picture Table Major Manufacturers of Tc-99 Figure I-123/131 Product Picture Table Major Manufacturers of I-123/131 Figure In-111 Product Picture Table Major Manufacturers of In-111 Figure Xe-133 Product Picture Table Major Manufacturers of Xe-133 Figure Th-201 Product Picture Table Major Manufacturers of Th-201 Figure Ga-67 Product Picture Table Major Manufacturers of Ga-67 Figure Other Product Picture Table Major Manufacturers of Other Table Global Nuclear Medicine Market Size Growth Rate by End User 2019-2025 (M Dose) Figure Diagnostic Figure Therapeutic Figure Nuclear Medicine Report Years Considered Figure Global Nuclear Medicine Market Size 2014-2025 (Million US$) Figure Global Nuclear Medicine Sales 2014-2025 (M Dose) Table Global Nuclear Medicine Market Size by Regions 2014-2019 (M Dose) & (Million US$) Table Global Nuclear Medicine Sales by Regions 2014-2019 (M Dose) Table Global Nuclear Medicine Sales Market Share by Regions 2014-2019 Figure Global Nuclear Medicine Sales Market Share by Regions 2014-2019 Figure 2018 Global Nuclear Medicine Sales Market Share by Regions Table Global Nuclear Medicine Revenue by Regions 2014-2019 (Million US$) Table Global Nuclear Medicine Revenue Market Share by Regions 2014-2019 Figure Global Nuclear Medicine Revenue Market Share by Regions 2014-2019 Figure 2018 Global Nuclear Medicine Revenue Market Share by Regions Table Global Nuclear Medicine Sales by Manufacturers (2014-2019) (M Dose) Table Global Nuclear Medicine Sales Share by Manufacturers (2014-2019) Figure Global Nuclear Medicine Sales Share by Manufacturers in 2018 Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Nuclear Medicine Revenue by Manufacturers (2014-2019) (Million USD) Table Nuclear Medicine Revenue Share by Manufacturers (2014-2019) Figure Nuclear Medicine Value Share by Manufacturers in 2018 Table Key Manufacturers Nuclear Medicine Price (2014-2019) (USD/Dose) Table Nuclear Medicine Manufacturers Manufacturing Base Distribution and Headquarters Table Manufacturers Nuclear Medicine Product Type Table Date of International Manufacturers Enter into Nuclear Medicine Market Table Manufacturers Mergers & Acquisitions, Expansion Plans Table Global Nuclear Medicine Sales by Product (2014-2019) (M Dose) Table Global Nuclear Medicine Sales Share by Product (2014-2019) Figure Global Nuclear Medicine Sales Market Share by Product (2014-2019) Figure Global Nuclear Medicine Sales Market Share by Product in 2018 Table Global Nuclear Medicine Revenue by Product (2014-2019) (Million US$) Table Global Nuclear Medicine Revenue Share by Product (2014-2019) Figure Global Nuclear Medicine Revenue Market Share by Product (2014-2019) Figure Global Nuclear Medicine Revenue Market Share by Product in 2018 Table Nuclear Medicine Price by Product 2014-2019 (USD/Dose) Table Global Nuclear Medicine Sales by End User (2014-2019) (M Dose) Table Global Nuclear Medicine Sales Share by End User (2014-2019) Figure Global Sales Nuclear Medicine Market Share by End User (2014-2019) Figure Global Sales Nuclear Medicine Market Share by End User in 2018 Figure North America Nuclear Medicine Sales Growth Rate 2014-2019 (M Dose) Figure North America Nuclear Medicine Revenue Growth Rate 2014-2019 (Million US$) Table North America Nuclear Medicine Sales by Countries (2014-2019) (M Dose) Table North America Nuclear Medicine Sales Market Share by Countries (2014-2019) Figure 2018 North America Nuclear Medicine Sales Market Share by Countries Table North America Nuclear Medicine Revenue by Countries (2014-2019) (Million US$) Table North America Nuclear Medicine Revenue Market Share by Countries (2014-2019) Figure 2018 North America Nuclear Medicine Revenue Market Share by Countries Figure United States Nuclear Medicine Sales Growth Rate (2014-2019) (M Dose) Figure United States Nuclear Medicine Revenue Growth Rate (2014-2019) (M Dose) Figure Canada Nuclear Medicine Sales Growth Rate (2014-2019) (M Dose) Figure Canada Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$) Figure Mexico Nuclear Medicine Sales Growth Rate (2014-2019) (M Dose) Figure Mexico Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$) Table North America Nuclear Medicine Sales by Product (2014-2019) (M Dose) Table North America Nuclear Medicine Sales Market Share by Product (2014-2019) Figure 2018 North America Nuclear Medicine Market Share by Product Table North America Nuclear Medicine Sales by End User (2014-2019) (M Dose) Table North America Nuclear Medicine Sales Market Share by End User (2014-2019) Figure 2018 North America Nuclear Medicine Market Share by End User Figure Europe Nuclear Medicine Sales Growth Rate 2014-2019 (M Dose) Figure Europe Nuclear Medicine Revenue Growth Rate 2014-2019 (Million US$) Table Europe Nuclear Medicine Sales by Countries (2014-2019) (M Dose) Table Europe Nuclear Medicine Sales Market Share by Countries (2014-2019) Figure 2018 Europe Nuclear Medicine Sales Market Share by Countries Table Europe Nuclear Medicine Revenue by Countries (2014-2019) (Million US$) Table Europe Nuclear Medicine Revenue Market Share by Countries (2014-2019) Figure 2018 Europe Nuclear Medicine Revenue Market Share by Countries Figure Germany Nuclear Medicine Sales Growth Rate (2014-2019) (M Dose) Figure Germany Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$) Figure France Nuclear Medicine Sales Growth Rate (2014-2019) (M Dose) Figure France Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$) Figure UK Nuclear Medicine Sales Growth Rate (2014-2019) (M Dose) Figure UK Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$) Figure Italy Nuclear Medicine Sales Growth Rate (2014-2019) (M Dose) Figure Italy Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$) Figure Russia Nuclear Medicine Sales Growth Rate (2014-2019) (M Dose) Figure Russia Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$) Table Europe Nuclear Medicine Sales by Product (2014-2019) (M Dose) Table Europe Nuclear Medicine Sales Market Share by Product (2014-2019) Figure 2018 Europe Nuclear Medicine Market Share by Product Table Europe Nuclear Medicine Sales by End User (2014-2019) (M Dose) Table Europe Nuclear Medicine Sales Market Share by End User (2014-2019) Figure 2018 Europe Nuclear Medicine Market Share by End User Figure Asia Pacific Nuclear Medicine Sales Growth Rate 2014-2019 (M Dose) Figure Asia Pacific Nuclear Medicine Revenue Growth Rate 2014-2019 (Million US$) Table Asia Pacific Nuclear Medicine Sales by Countries (2014-2019) (M Dose) Table Asia Pacific Nuclear Medicine Sales Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Nuclear Medicine Sales Market Share by Countries Table Asia Pacific Nuclear Medicine Revenue by Countries (2014-2019) (Million US$) Table Asia Pacific Nuclear Medicine Revenue Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Nuclear Medicine Revenue Market Share by Countries Figure China Nuclear Medicine Sales Growth Rate (2014-2019) (M Dose) Figure China Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$) Figure Japan Nuclear Medicine Sales Growth Rate (2014-2019) (M Dose) Figure Japan Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$) Figure Korea Nuclear Medicine Sales Growth Rate (2014-2019) (M Dose) Figure Korea Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$) Figure India Nuclear Medicine Sales Growth Rate (2014-2019) (M Dose) Figure India Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$) Figure Australia Nuclear Medicine Sales Growth Rate (2014-2019) (M Dose) Figure Australia Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$) Figure Indonesia Nuclear Medicine Sales Growth Rate (2014-2019) (M Dose) Figure Indonesia Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$) Figure Malaysia Nuclear Medicine Sales Growth Rate (2014-2019) (M Dose) Figure Malaysia Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$) Figure Philippines Nuclear Medicine Sales Growth Rate (2014-2019) (M Dose) Figure Philippines Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$) Figure Thailand Nuclear Medicine Sales Growth Rate (2014-2019) (M Dose) Figure Thailand Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$) Figure Vietnam Nuclear Medicine Sales Growth Rate (2014-2019) (M Dose) Figure Vietnam Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$) Figure Singapore Nuclear Medicine Sales Growth Rate (2014-2019) (M Dose) Figure Singapore Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$) Table Asia Pacific Nuclear Medicine Sales by Product (2014-2019) (M Dose) Table Asia Pacific Nuclear Medicine Sales Market Share by Product (2014-2019) Figure 2018 Asia Pacific Nuclear Medicine Market Share by Product Table Asia Pacific Nuclear Medicine Sales by End User (2014-2019) (M Dose) Table Asia Pacific Nuclear Medicine Sales Market Share by End User (2014-2019) Figure 2018 Asia Pacific Nuclear Medicine Market Share by End User Figure Central & South America Nuclear Medicine Sales Growth Rate 2014-2019 (M Dose) Figure Central & South America Nuclear Medicine Revenue Growth Rate 2014-2019 (Million US$) Table Central & South America Nuclear Medicine Sales by Countries (2014-2019) (M Dose) Table Central & South America Nuclear Medicine Sales Market Share by Countries (2014-2019) Figure 2018 Central & South America Nuclear Medicine Sales Market Share by Countries Table Central & South America Nuclear Medicine Revenue by Countries (2014-2019) (Million US$) Table Central & South America Nuclear Medicine Revenue Market Share by Countries (2014-2019) Figure 2018 Central & South America Nuclear Medicine Revenue Market Share by Countries Figure Brazil Nuclear Medicine Sales Growth Rate (2014-2019) (M Dose) Figure Brazil Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$) Figure Argentina Nuclear Medicine Sales Growth Rate (2014-2019) (M Dose) Figure Argentina Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$) Table Central & South America Nuclear Medicine Sales by Product (2014-2019) (M Dose) Table Central & South America Nuclear Medicine Sales Market Share by Product (2014-2019) Figure 2018 Central & South America Nuclear Medicine Market Share by Product Table Central & South America Nuclear Medicine Sales by End User (2014-2019) (M Dose) Table Central & South America Nuclear Medicine Sales Market Share by End User (2014-2019) Figure 2018 Central & South America Nuclear Medicine Market Share by End User Figure Middle East and Africa Nuclear Medicine Sales Growth Rate 2014-2019 (M Dose) Figure Middle East and Africa Nuclear Medicine Revenue Growth Rate 2014-2019 (Million US$) Table Middle East and Africa Nuclear Medicine Sales by Countries (2014-2019) (M Dose) Table Middle East and Africa Nuclear Medicine Sales Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Nuclear Medicine Sales Market Share by Countries Table Middle East and Africa Nuclear Medicine Revenue by Countries (2014-2019) (Million US$) Table Middle East and Africa Nuclear Medicine Revenue Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Nuclear Medicine Revenue Market Share by Countries Figure GCC Countries Nuclear Medicine Sales Growth Rate (2014-2019) (M Dose) Figure GCC Countries Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$) Figure Turkey Nuclear Medicine Sales Growth Rate (2014-2019) (M Dose) Figure Turkey Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$) Figure Egypt Nuclear Medicine Sales Growth Rate (2014-2019) (M Dose) Figure Egypt Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$) Figure South Africa Nuclear Medicine Sales Growth Rate (2014-2019) (M Dose) Figure South Africa Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$) Table Middle East and Africa Nuclear Medicine Sales by Product (2014-2019) (M Dose) Table Middle East and Africa Nuclear Medicine Sales Market Share by Product (2014-2019) Figure 2018 Middle East and Africa Nuclear Medicine Market Share by Product Table Middle East and Africa Nuclear Medicine Sales by End User (2014-2019) (M Dose) Table Middle East and Africa Nuclear Medicine Sales Market Share by End User (2014-2019) Figure 2018 Middle East and Africa Nuclear Medicine Market Share by End User Table GE Healthcare Company Details Table GE Healthcare Nuclear Medicine Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019) Table GE Healthcare Recent Development Table Bracco Imaging Company Details Table Bracco Imaging Nuclear Medicine Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019) Table Bracco Imaging Recent Development Table Mallinckrodt Company Details Table Mallinckrodt Nuclear Medicine Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019) Table Mallinckrodt Recent Development Table Lantheus Medical Imaging Company Details Table Lantheus Medical Imaging Nuclear Medicine Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019) Table Lantheus Medical Imaging Recent Development Table Bayer Company Details Table Bayer Nuclear Medicine Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019) Table Bayer Recent Development Table Triad Isotopes Company Details Table Triad Isotopes Nuclear Medicine Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019) Table Triad Isotopes Recent Development Table Nordion Company Details Table Nordion Nuclear Medicine Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019) Table Nordion Recent Development Table Jubilant Pharma Company Details Table Jubilant Pharma Nuclear Medicine Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019) Table Jubilant Pharma Recent Development Table Eli Lilly Company Details Table Eli Lilly Nuclear Medicine Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019) Table Eli Lilly Recent Development Table SIEMENS Company Details Table SIEMENS Nuclear Medicine Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019) Table SIEMENS Recent Development Table China Isotope & Radiation Company Details Table Dongcheng Company Details Table Global Nuclear Medicine Sales Forecast by Regions 2019-2025 (M Dose) Table Global Nuclear Medicine Sales Market Share Forecast by Regions 2019-2025 Table Global Nuclear Medicine Revenue Forecast by Regions 2019-2025 (Million US$) Table Global Nuclear Medicine Revenue Market Share Forecast by Regions 2019-2025 Table Global Nuclear Medicine Sales Forecast by Product 2019-2025 (M Dose) Table Global Nuclear Medicine Sales Market Share Forecast by Product 2019-2025 Table Global Nuclear Medicine Revenue Forecast by Product 2019-2025 (Million US$) Table Global Nuclear Medicine Revenue Market Share Forecast by Product 2019-2025 Table Global Nuclear Medicine Sales Forecast by End User 2019-2025 (M Dose) Table Global Nuclear Medicine Sales Market Share Forecast by End User 2019-2025 Figure North America Nuclear Medicine Sales Growth Rate Forecast (2019-2025) (M Dose) Figure North America Nuclear Medicine Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Europe Nuclear Medicine Sales Growth Rate Forecast (2019-2025) (M Dose) Figure Europe Nuclear Medicine Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Asia Pacific Nuclear Medicine Sales Growth Rate Forecast (2019-2025) (M Dose) Figure Asia Pacific Nuclear Medicine Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Central & South America Nuclear Medicine Sales Growth Rate Forecast (2019-2025) (M Dose) Figure Central & South America Nuclear Medicine Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Middle East and Africa Nuclear Medicine Sales Growth Rate Forecast (2019-2025) (M Dose) Figure Middle East and Africa Nuclear Medicine Revenue Growth Rate Forecast (2019-2025) (Million US$) Table Nuclear Medicine Value Chain Table Nuclear Medicine Customers List Table Nuclear Medicine Distributors List Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

GE Healthcare Bracco Imaging Mallinckrodt Lantheus Medical Imaging Bayer Triad Isotopes Nordion Jubilant Pharma Eli Lilly SIEMENS China Isotope & Radiation Dongcheng